Detection of Serotype-Specific Antibodies to the Four Dengue Viruses Using an Immune Complex Binding (ICB) ELISA

• Published in: PLoS neglected tropical diseases Vol. 7; no. 12; p. e2580
• Main Authors: Emmerich, Petra, Mika, Angela, Schmitz, Herbert
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.12.2013; Public Library of Science (PLoS)
• Subjects: Adolescent; Adult; Antibodies; Antibodies, Viral - blood; Antigen-Antibody Complex - analysis; Antigens, Viral - genetics; Binding sites (Biochemistry); Clinical Laboratory Techniques - methods; Dengue - diagnosis; Dengue - immunology; Dengue fever; Dengue virus; Dengue Virus - immunology; Dengue viruses; Enzyme-linked immunosorbent assay; Enzyme-Linked Immunosorbent Assay - methods; Enzymes; Female; Health aspects; Host-parasite relationships; Humans; Infections; Male; Methods; Middle Aged; Mortality; Physiological aspects; Recombinant Proteins - genetics; Time Factors; Vietnam; Viral antibodies; Virus research; Viruses; Young Adult; Vietnam; Germany; Antigen-Antibody Complex; Enzyme-Linked Immunosorbent Assay; Clinical Laboratory Techniques; Dengue; Humans; Middle Aged; Male; Recombinant Proteins; Antibodies, Viral; Dengue Virus; Young Adult; Vietnam; Antigens, Viral; Time Factors; Adolescent; Adult; Female
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0002580

Dengue virus (DENV) infections are preferentially diagnosed by detection of specific IgM antibodies, DENV NS1 antigen assays or by amplification of viral RNA in serum samples of the patients. The type-specific immunity to the four worldwide circulating DENV serotypes can be determined by neutralization assays. An alternative to the complicated neutralization assays would be helpful to study the serotype-specific immune response in people in DENV hyperendemic areas but also in subjects upon DENV vaccination. In consecutive samples of patients with DENV-1- 4 infection type-specific antibodies were detected using an immune complex binding (ICB) ELISA. During incubation of serum samples and enzyme- labeled recombinant envelope domain III (EDIII) antigens immune complexes (ICs) are formed, which are simultaneously bound to a solid phase coated with an Fc-receptor (CD32). After a single washing procedure the bound labeled ICs can be determined. To further improve type-specific reactions high concentrations of competing heterologous unlabeled ED III proteins were added to the labeled antigens. Follow-up serum samples of 64 patients with RT-PCR confirmed primary DENV-1, -2, -3 or -4 infections were tested against four enzyme-labeled recombinant DENV EDIII antigens. Antibodies to the EDIII antigens were found in 55 patients (sensitivity 86%). A complete agreement between the serotype detected by PCR in early samples and the serotype-specific antibody in later samples was found. Type-specific anti-EDIII antibodies were first detected 9-20 days after onset of the disease. In 21% of the samples collected from people in Vietnam secondary infections with antibodies to two serotypes could be identified. The data obtained with the ICB-ELISA show that after primary DENV infection the corresponding type-specific antibodies are detected in almost all samples collected at least two weeks after onset of the disease. The method will be of value to determine the distribution of the various type-specific anti-DENV antibodies in DENV endemic areas.